Holuka Eugene Myron has filed 9 insider transactions across 2 companies since March 2024.
Most recent transaction: a grant/award of 300000 shares of CITIUS ONCOLOGY, INC. ($CTOR) on September 19, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sept. 19, 2025 | CITIUS ONCOLOGY, INC. | $CTOR | Holuka Eugene Myron | Director | A | Common Stock | 300000 | $0.00 | 300,000.0000 | 71,552,402 | 9999.99% | 0.42% |
| Sept. 19, 2025 | CITIUS ONCOLOGY, INC. | $CTOR | Holuka Eugene Myron | Director | A | Common Stock | 300000 | $0.00 | 300,000.0000 | 71,552,402 | 9999.99% | 0.42% |
| Sept. 19, 2025 | CITIUS ONCOLOGY, INC. | $CTOR | Holuka Eugene Myron | Director | A | Common Stock | 300000 | $0.00 | 300,000.0000 | 71,552,402 | 9999.99% | 0.42% |
| Dec. 12, 2024 | CITIUS ONCOLOGY, INC. | $CTOR | Holuka Eugene Myron | Director | A | Stock Option (Right to Buy) | 125000 | $0.00 | 275,000.0000 | 68,053,607 | 83.33% | 0.18% |
| Nov. 7, 2024 | Citius Pharmaceuticals, Inc. | $CTXR | Holuka Eugene Myron | Director | A | Stock Option (Right to Purchase Common Stock) | 125000 | $0.00 | 513,334.0000 | 6,726,999 | 32.19% | 1.86% |
| March 13, 2024 | Citius Pharmaceuticals, Inc. | $CTXR | Holuka Eugene Myron | Director | M | Stock Option (Right to Purchase Common Stock) | 2415 | $0.00 | 388,334.0000 | 6,358,237 | 0.62% | 0.04% |
| March 13, 2024 | Citius Pharmaceuticals, Inc. | $CTXR | Holuka Eugene Myron | Director | F | Common Stock | 48 | $0.75 | 2,367.0000 | 6,358,237 | 1.99% | 0.00% |
| March 13, 2024 | Citius Pharmaceuticals, Inc. | $CTXR | Holuka Eugene Myron | Director | M | Common Stock | 2415 | $0.02 | 2,415.0000 | 6,358,237 | 9999.99% | 0.04% |
| Aug. 12, 2024 | CITIUS ONCOLOGY, INC. | $CTOR | Holuka Eugene Myron | Director | A | Stock Option (Right to Buy) | 150000 | $0.00 | 150,000.0000 | 67,500,000 | 9999.99% | 0.22% |